Phosphodiesterase 3 Inhibitor
9 drugs across 4 manufacturers|9 Generic,0 Brand
The Phosphodiesterase 3 Inhibitor class contains 9 NDCs from 4 manufacturers (9 generic, 0 brand), at an average NADAC of $0.13 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
9
9G / 0B
Manufacturers
4
Avg $0.1312/unit
Avg 7d Change
+2.43%
Across 9 drugs with changes
7d Activity
of 9 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
4 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CILOSTAZOL 100 MG TABLET Cilostazol | $0.1318 per EA | -2.12% |
CILOSTAZOL 100 MG TABLET Cilostazol | $0.1318 per EA | -2.12% |
CILOSTAZOL 100 MG TABLET cilostazol | $0.1318 per EA | -2.12% |
CILOSTAZOL 100 MG TABLET cilostazol | $0.1318 per EA | -2.12% |
CILOSTAZOL 100 MG TABLET cilostazol | $0.1318 per EA | -2.12% |
CILOSTAZOL 50 MG TABLET Cilostazol | $0.1304 per EA | +6.97% |
CILOSTAZOL 50 MG TABLET cilostazol | $0.1304 per EA | +6.97% |
CILOSTAZOL 50 MG TABLET cilostazol | $0.1304 per EA | +6.97% |
CILOSTAZOL 50 MG TABLET cilostazol | $0.1304 per EA | +6.97% |
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
cilostazol market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Phosphodiesterase 3 Inhibitor class?
The Phosphodiesterase 3 Inhibitor class contains 9 NDCs from 4 manufacturers — 9 generic and 0 brand products.
What is the average price of Phosphodiesterase 3 Inhibitor drugs?
The average NADAC for the Phosphodiesterase 3 Inhibitor class is $0.1312 per unit across 9 NDCs.
Which manufacturers make Phosphodiesterase 3 Inhibitor drugs?
4 manufacturers make drugs in the Phosphodiesterase 3 Inhibitor class. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (3), AvPAK (2), Apotex Corp. (2), Slate Run Pharmaceuticals LLC (2).
How has Phosphodiesterase 3 Inhibitor pricing changed recently?
Over the past 7 days, 4 NDCs in this class rose and 5 fell, with a class-wide average change of +2.4%.